KRISP is based at the Nelson R Mandela School of Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa. We are also associated to the Centre for the Aids Programme of Research in South Africa (CAPRISA) and the Africa Health Research Institute (AHRI). Bioinformatics servers are kindly mantained by the South African Medical Research Council (MRC). Please use KRISP website to get information on our research. The Bioafrica.net will be maintained for historical reasons for the next couple of years.
By Katharine Child, 05 December 2017. SA's policy to reduce HIV infections is to do what the UN recommends, which is to get 90% of people tested, 90% of HIV-positive people taking antiretrovirals and 90% of those on treatment taking it properly so they are not infectious. This will ultimately decrease the rate of new infections...
By Linda Nordling, 2 December 2017, Quartz Africa. Antiretrovirals 'the drugs used to keep HIV in check' don't only prevent people from getting AIDS; they also keep virus levels low, making those taking them less likely to pass the infection to others.
HIV drug resistance is approaching and exceeding 10% in people living with HIV who are about to initiate or reinitiate first-line antiretroviral therapy, according to the largest meta-analysis to date on HIV drug resistance.